Icaritin greatly attenuates β‐amyloid‐induced toxicity in vivo
Liangxian Li,Zaiwa Wei,Yafang Tang,Mingyue Jin,Hua Yao,Xia Li,Qinghua Li,Jie Tan,Bo Xiao
DOI: https://doi.org/10.1111/cns.14527
2023-11-21
CNS Neuroscience & Therapeutics
Abstract:Abstract Aims The accumulation and deposition of β‐amyloid (Aβ) has always been considered a major pathological feature of Alzheimer's disease (AD). The latest and mainstream amyloid cascade hypothesis indicates that all the main pathological changes in AD are attributed to the accumulation of soluble Aβ. However, the exploration of therapeutic drugs for Aβ toxicity has progressed slowly. This study aims to investigate the protective effects of Icaritin on the Aβ‐induced Drosophila AD model and its possible mechanism. Methods To identify the effects of Icaritin on AD, we constructed an excellent Drosophila AD model named Aβ arc (arctic mutant Aβ 42 ) Drosophila . Climbing ability, flight ability, and longevity were used to evaluate the effects of Icaritin on AD phenotypes. Aβ arc was determined by immunostaining and ELISA. To identify the effects of Icaritin on oxidative stress, we performed the detection of ROS, hydrogen peroxide, MDA, SOD, catalase, GST, and Caspase‐3. To identify the effects of Icaritin on energy metabolism, we performed the detection of ATP and lactate. Transcriptome analysis and qRT‐PCR verifications were used to detect the genes directly involved in oxidative stress and energy metabolism. Mitochondrial structure and function were detected by an electron microscopy assay, a mitochondrial membrane potential assay, and a mitochondrial respiration assay. Results We discovered that Icaritin almost completely rescues the climbing ability, flight ability, and longevity of Aβ arc Drosophila . Aβ arc was dramatically reduced by Icaritin treatment. We also found that Icaritin significantly reduces oxidative stress and greatly improves impaired energy metabolism. Importantly, transcriptome analysis and qRT‐PCR verifications showed that many key genes, directly involved in oxidative stress and energy metabolism, are restored by Icaritin. Next, we found that Icaritin perfectly restores the integrity of mitochondrial structure and function damaged by Aβ arc toxicity. Conclusion This study suggested that Icaritin is a potential drug to deal with the toxicity of Aβ arc, at least partially realized by restoring the mitochondria/oxidative stress/energy metabolism axis, and holds potential for translation to human AD.
pharmacology & pharmacy,neurosciences